Topic: Pharma
Some 160 jobs are to go at the Schering Plough pharmaceutical plant in west Cork, it emerged this afternoon.The jobs will be cut over three years as part of a cost-cutting iniative, staff were told a ... moreSome 160 jobs are to go at the Schering Plough pharmaceutical plant in west Cork, it emerged this afternoon.The jobs will be cut over three years as part of a cost-cutting iniative, staff were told a ... more
Updated Date: Sep 9, 2010 EST ... more
Enobia Pharma provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hyp ... more
N30 Pharmaceuticals, LLC announced it has dosed the first human subject with N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR). N6022 is the first GSNOR inhibitor to be admin ... more
BioAlliance Pharma SA (Paris:BIO)(Euronext Paris - BIO), a company dedicated to the supportive care and treatment of cancer patients, announced the grant of a European patent protecting its product ac ... more
Hello, everyone, nice to see you again. A sunny day is dawning here on the Pharmalot corporate campus, where the short people are off to the schoolhouse for another year of adventure and, hopefully, a ... more
Updated Date: Sep 7, 2010 EST ... more
Updated Date: Sep 7, 2010 EST ... more
Welcome back, everyone. We hope your weekend was splendid and you had a chance to recharge. The weather, after all, was magnificent. Now, of course, the time has come to return to the routine. So as y ... more
Here #8217;s a reason to expect drugmakers to lust after continuing medical education. A new survey finds that 71 percent of doctors who absolutely refuse to see pharma sales reps will break down and ... more
A new study finds that the aluminum content of infant formula remains unacceptably high and one of the manufacturers cited is SMA Nutrition, a company based in the UK and owned by Pfizer. The issue is ... more
Last December, the Senate Finance Committee €™s Chuck Grassley sent letters 33 medical advocay groups, including the American Medical Association, the American Cancer Society, the American Heart Assoc ... more
http://www.tc.umn.edu/~ellio023/documents/ElliottDrugPushers.pdf"Making A Killing", Mother Jones, September/October 2010.(with Roberto Abadie) Exploiting a Research Underclass in Phase 1 Clinical Tri ... more
http://www.tc.umn.edu/~ellio023/documents/ElliottDrugPushers.pdf"Making A Killing", Mother Jones, September/October 2010.(with Roberto Abadie) Exploiting a Research Underclass in Phase 1 Clinical Tri ... more
MSD (known in the and as Merck) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of 'Brinavess' „¢ (vernakalant) has been granted marketing ... more
Peter Mansell explores how effective concordance can take the strain off industry-patient group partnerships. Pharmaceutical companies and patient organizations are never going to be the easiest of fi ... more
Celgene Corporation (NASDAQ: CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application ( ... more
Celgene Corporation (NASDAQ: CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application ( ... more
by Drew Rosielle, MDRecently, the New York Times reported of the movement in Washington State to officially do something about prescription opioid abuse, coming on the heels of course of the FDA rejec ... more
by Larry Husten, PhDThe authors call it €œan in-office linguistic study € and write that it €œwas conducted to assess physician €“patient discussions of mixed dyslipidemia. €Â But it €™s really ... more
Updated Date: Sep 3, 2010 EST ... more
Good morning, everyone. How are you today? Slowing down just a bit, perhaps? Here in the states, of course, a three-day weekend is fast approaching. And so we will pull in the sidewalks early. We hope ... more
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we €™ll share with it others. That €™s right. Send us your announcements and w ... more
The speculation earlier this week that Roche was planning a round of cutbacks is, in fact, on the money. After a scheduled managerial meeting, the drugmaker issued a statement using the usual euphemis ... more
Clinical trials for promising new drug candidate are planned LA JOLLA, CA – August 30, 2010 –– An international team led by scientists from The Scripps Research Institute, the Swiss Tropical Instit ... more
by WhiteCoat, MDAfter seeing Mrs. WhiteCoat argue on the phone with Medco representatives for 20 minutes about why one of her 80+ year old patients hadn €™t received her medicine despite three lost ... more
Top of the morning to you. A sparkly day is unfolding here on the Pharmalot corporate campus, where we are following various leads and trying to make sense of this big old world. To help the process, ... more
Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS „¢ (vernakalant) ha ... more
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for t ... more
Updated Date: Sep 1, 2010 EST ... more
Updated Date: Sep 1, 2010 EST ... more
How #8217;s this for unusual? Over the course of a three-month inspection earlier this year, FDA inspectors found something interesting at the Sun Pharmaceuticals plant in Cranbury, New Jersey - implo ... more
For those keeping score, the latest monthly tally of job cuts in the pharmaceutical industry numbered just 200 in August, according to Challenger, Gray #038; Christmas, the outplacement consulting fi ... more
Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of drug development setbacks. Swiss newspaper Sonntag says the company is planning ... more
Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of drug development setbacks. Swiss newspaper Sonntag says the company is planning ... more
by Paul Sax, MDLast year, I commented on the ironic sameness of ICU infectious diseases €” that incredibly sick, complex patients entered the ICU with vastly different problems, then over time, see ... more
Updated Date: Aug 31, 2010 EST ... more
The drugmaker recently discussed cutbacks at a management meeting and the number of jobs being considered for elimination are expected to be in the thousands, and come not only from sales and marketin ... more
The "patent cliff" is the chief challenge facing the industry, although some companies will be affected more than others. Patents can sometimes be extended by making slight changes to the chemica ... more
The "patent cliff" is the chief challenge facing the industry, although some companies will be affected more than others. Patents can sometimes be extended by making slight changes to the chemica ... more
by Daniel Carlat, MDI recently debated Steve DiFillippo, owner of Davio #8217;s and Avila #8217;s restaurants, on the WGBH program Greater Boston, hosted by Emily Rooney. The topic? The effect of the ... more
by Claudia M. Gold, MDRecently while cleaning out my office in anticipation of my new job, I discovered that I had unknowingly been witness to to an historic moment in child psychiatry. I found a bi ... more
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we €™ll share with it others. That €™s right. Send us your announcements and w ... more
For all the talk about embracing the Internet and social media, the amount of healthcare and pharma ad spending online will remain steady at about 4 percent of the total in 2014, even as the annual pr ... more
by Eric Van De Graaff, MDThere is no class of medications in the history of the world that has been better studied that statins.This class of drugs is more properly termed HMG CoA reductase (3-hydr ... more
Updated Date: Aug 27, 2010 EST ... more
Updated Date: Aug 27, 2010 EST ... more
An excerpt from Unhinged: The trouble with psychiatry- a doctor €™s revelations about a profession in crisis. Copyright © 2010 Daniel Carlat. Excerpted with permission by Free Press, a Division of Si ... more
Updated Date: Aug 26, 2010 EST ... more
Updated Date: Aug 26, 2010 EST ... more
You have to figure that whoever cut a hole in the roof at an Eli Lilly warehouse earlier this year had to be organized - and in more than one sense of the word (see here). But it #8217;s not just your ... more
Concerned that many of its drugmakers may be taken over in a wave of mergers and acquisitions, the Indian government is being urged to consider compulsory licensing to assure that prices - particularl ... more
We spend a fair amount of time on this site tracking the controversy over continuing medical education and the extent to which industry may unduly influence the physician mindset. For the second year ... more
Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynae ... more
Tranzyme Pharma announced that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will p ... more
Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynae ... more
Hat tip: Fid ... more
Hat tip: Fid ... more
Good morning, everyone. Nice to see you again. After a protracted stretch, we have returned to the Pharmalot corporate campus, where a spot of rain is falling. We are keeping busy, of course, with the ... more
An excerpt from White Coat, Black Hat.by Carl ElliottA few years ago a small group of first-year medical students at the University of Minnesota spoke to me about a lecture on erectile dysfunction ... more
3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc. ... more
Updated Date: Aug 24, 2010 EST ... more
Updated Date: Aug 24, 2010 EST ... more
Updated Date: Aug 24, 2010 EST ... more
Usually, this site contents itself with issues pertaining to medicines, but given the unusual string of difficulties that Johnson #038; Johnson is having with quality control, we thought we would not ... more
What do Americans think about when they think about prescription drugs? A new survey finds that cost, safety and industry influence over physicians are on a lot of minds. The overall picture suggests ... more
Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, announced the location of its new US headquarters in Bedminster, New Jersey. Arc ... more
Tel Aviv University develops nano-vehicle to deliver chemotherapy treatments on target Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver to ... more
Hello, everyone. Nice to see you again. As promised, we have returned. We trust you had a pleasant and productive week while we were away. And we want to say thanks for the nice send-off notes so many ... more
For those of you who, like us, took a respite last week, we thought we would also recap a few of the more interesting events of the past several days. Please forgive us if one or more of these items s ... more
Preemption survives another test. A federal appeals in Ohio court last week partially reinstated a lawsuit over the Redux diet pill after deciding that FDA approval did not preempt state claims that W ... more
Given that patient and consumer groups are increasingly involved in as stakeholders and experts in management and scientific committees at the European Medicines Agency, one activist group decided to ... more
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today ... more
Watson Pharmaceuticals, Inc.(NYSE: WPI), announced that it intends to launch ella(R) (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement fo ... more
Updated Date: Aug 20, 2010 EST ... more
In the September issue of Mother Jones magazine, Dr. Carl Elliott, a professor of bioethics at the University of Minnesota, writes about the suicide in 2004 of 26-year-old Dan Markingson, who was enr ... more
In the September issue of Mother Jones magazine, Dr. Carl Elliott, a professor of bioethics at the University of Minnesota, writes about the suicide in 2004 of 26-year-old Dan Markingson, who was enr ... more
Mirus Bio now offers a new transfection kit ideal for biotherapeutic protein production in large pharma and biotech settings. Mirus Bio's new TransIT-PRO „¢ Kit will decrease time to produce usable pr ... more
by Marya Zilberberg, MD, MPHIt is not a secret that large sums of money have passed from the pharmaceutical and device manufacturers into physicians #8217; hands.This money has been paid not only fo ... more
Updated Date: Aug 19, 2010 EST ... more
Updated Date: Aug 19, 2010 EST ... more
Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets. These generic ... more
We can only imagine how excited the folks at a small pharmaceutical development company called Verus were when they signed a deal with the mighty AstraZeneca in the spring of 2007. AstraZeneca agreed ... more
You tell me!http://www.tranzyme.com/ ... more
We can only imagine how excited the folks at a small pharmaceutical development company called Verus were when they signed a deal with the mighty AstraZeneca in the spring of 2007. AstraZeneca agreed ... more
You tell me!http://www.tranzyme.com/ ... more
c="http://www.kevinmd.com/blog/wp-content/plugins/tweetbutton-for-wordpress/images/tweet.png" style="border:none" title="Incentives for switching patients from branded drugs to generic" alt="Incentiv ... more
c="http://www.kevinmd.com/blog/wp-content/plugins/tweetbutton-for-wordpress/images/tweet.png" style="border:none" title="Physicians should not be used for FDA ad enforcement " alt="Physicians should ... more
Updated Date: Aug 18, 2010 EST ... more
Updated Date: Aug 18, 2010 EST ... more
After taking the rare step of ordering the FTC to respond to interrogatories about why it wanted to subpoena the CEO of Watson Pharmaceuticals regarding a reverse-payment settlement the company entere ... more
Find someone with vodka!The global pharmaceutical industry is little more than a "market for lemons" that dupes doctors and patients about the effectiveness of its products, a report has said.Professo ... more
After taking the rare step of ordering the FTC to respond to interrogatories about why it wanted to subpoena the CEO of Watson Pharmaceuticals regarding a reverse-payment settlement the company entere ... more
Find someone with vodka!The global pharmaceutical industry is little more than a "market for lemons" that dupes doctors and patients about the effectiveness of its products, a report has said.Professo ... more
c="http://www.kevinmd.com/blog/wp-content/plugins/tweetbutton-for-wordpress/images/tweet.png" style="border:none" title="Creatine causing muscle cramps and how supplements may be dangerous" alt="Crea ... more
Updated Date: Aug 17, 2010 EST ... more
Double standard for big pharma bribes By Shelley DuBois, reporterAugust 17, 2010: 11:44 AM ETFORTUNE -- Legally, of course, companies can't bribe anyone to do anything, whether the kickback is takin ... more
Double standard for big pharma bribes By Shelley DuBois, reporterAugust 17, 2010: 11:44 AM ETFORTUNE -- Legally, of course, companies can't bribe anyone to do anything, whether the kickback is takin ... more
PharmaTimes | Industry News | World News | US Justice Departments investigates pharma for corruption
PharmaTimes | Industry News | World News | US Justice Departments investigates pharma for corruption
Updated Date: Aug 16, 2010 EST ... more
Updated Date: Aug 16, 2010 EST ... more
The world's largest pharmaceutical companies are facing a corruption investigation in the United States over claims that the hospitality lavished on those who prescribe their treatments could constit ... more
The world's largest pharmaceutical companies are facing a corruption investigation in the United States over claims that the hospitality lavished on those who prescribe their treatments could constit ... more
FDA approves new morning-after pill | Philadelphia Inquirer | 08/14/2010: "WASHINGTON - The Food and Drug Administration on Friday approved a new type of morning-after contraceptive that works longer ... more
FDA approves new morning-after pill | Philadelphia Inquirer | 08/14/2010: "WASHINGTON - The Food and Drug Administration on Friday approved a new type of morning-after contraceptive that works longer ... more
Updated Date: Aug 13, 2010 EST ... more
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we €™ll share with it others. That €™s right. Send us your announcements and w ... more
by Richard MeyerTop of mind positioning has been replaced with top of page positioning. The old ad model of informing, persuading and reminding are being replaced by involvement, community and ... more
For Daiichi-Sankyo, things keep going from bad to worse at its Ranbaxy Laboratories unit. Atul Sobti resigned today as ceo of the Indian drugmaker, which has been struggling to correct manufacturing p ... more
The US Department of Justice is scrutinising payments by leading pharmaceuticals companies for hospitality, consultants, licensing agreements and charitable donations in markets around the world as p ... more
The US Department of Justice is scrutinising payments by leading pharmaceuticals companies for hospitality, consultants, licensing agreements and charitable donations in markets around the world as p ... more
Why do some people volunteer for clinical trials? Are they aware of the risks? Are they treated properly? What kind of follow up should take place? These are among the issues that Roberto Abadie, a vi ... more
A new study claims a new superbug that is resistant to even the most powerful antibiotics has entered UK hospitals, and the researchers trace what they say is a potentially global health problem back ... more
by Steve WoodruffOne recent news item in the world of pharma is the less-than-enthusiastic response of an FDA panel to Boehringer-Ingelheim €™s experimental €œsexual desire for women € pill, f ... more
Updated Date: Aug 11, 2010 EST ... more
Top of the morning to you. And a sunny one it is. Hope your day is getting off to a good start. As for us, we have the usual laundry list of meetings and deadlines, which calls for a cup of stimulatio ... more
Now that the World Health Organization has officially declared that the swine flu pandemic is over (see this), the agency has finally released the names of the scientific advisors who helped with pand ... more
Good morning, everyone. Another balmy day on the Pharmalot corporate campus, where we are doing our best to keep cool. We trust you are doing the same. Meanwhile, deadlines and meetings continue to lo ... more
Pharma lobbyists on Capitol Hill and academics at major universities may be rejoicing tonight at the news that Paul Thacker, an investigator for US Senator Chuck Grassley, is leaving to join the Proje ... more
Peter Mansell reports on how compliance and personal monitoring technologies can help pharma firms better tailor their offerings to different patient groups. New technology is the lifeblood of drug de ... more
Hello, everyone, and welcome to another working week - unless you happen to be on vacation. For those of us who remain very much grounded in the routine, however, today ushers in yet another series of ... more
As promised, the US Justice Department - along with the US Securities and Exchange Commission - is paying closer attention to interactions between the pharmaceutical industry and foreign governments ( ... more
iiBIG presents the Next Generation Pharma Sales Marketing Summit, to be held November 16-17, 2010 at the Inner Harbor Marriott Hotel in Baltimore, MD. This networking and educational forum will prov ... more
Acceleron Pharma has gained FDA Fast Track designation for ACE-031 which will help to speed its journey through the drug approval process. ACE-031 is a substance that may be able to increase the size ... more
A robust over-the-counter (OTC) drug market exists in less developed regions, where OTC is often the most practical distribution method, according to medical market research publisher Kalorama Informa ... more
Clavis Pharma (OSE: CLAVIS), the Norwegian cancer drug development company, and its partner Clovis Oncology, Inc. announce that the first two patients have been recruited into a Phase II clinical stud ... more
Are The Media Going Off Their Meds? « Mike Huckman's Blog: "Healthcare (some people, including me, think it €™s one word, others say two) bloggers are demanding to be treated by PR as journalism equa ... more
Are The Media Going Off Their Meds? « Mike Huckman's Blog: "Healthcare (some people, including me, think it €™s one word, others say two) bloggers are demanding to be treated by PR as journalism equa ... more
Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium ... more
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we €™ll share with it others. That €™s right. Send us your announcements and w ... more
Pharmaceutical companies in the UK will have to declare the amount of money paid to its healthcare professionals who act as €˜consultants €™ or Key Opinion Leaders (KOLs) under proposed new rules.The ... more
Pharmaceutical companies in the UK will have to declare the amount of money paid to its healthcare professionals who act as €˜consultants €™ or Key Opinion Leaders (KOLs) under proposed new rules.The ... more
A Pennsylvania court has offered another legal claim that consumers can pursue when filing product-liability lawsuits against drugmakers in the state. In a ruling involving the Redux diet pill, a Penn ... more
Why is AZ engaging in what appears to be death by a thousand legal cuts? It turns out that when you run the numbers, there €™s a case to be made that it €™s actually cheaper for AZ to lift its Seroqu ... more
Why is AZ engaging in what appears to be death by a thousand legal cuts? It turns out that when you run the numbers, there €™s a case to be made that it €™s actually cheaper for AZ to lift its Seroqu ... more
Hello, everyone. How are you today? Hope your week is going well. We have had a rather busy time, but that is to be expected. And so you know what this means - time for two cups of stimulation. Feel f ... more
Joining a small, but growing list of academic institutions, the University of Minnesota has adopted new rules governing conflicts of interest for its med school employees, The Minneapolis Star-Tribune ... more
by Randall S. Bock, MD It is insulting to think that doctors who are ostensibly smart enough to save one #8217;s life are in fact so stupid, or merely gullible enough, to be swept ... more
N30 Pharmaceuticals, LLC announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathio ... more
News reports cover developments in the pharmaceutical and medical device industries. The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to subm ... more
Good morning, all. Nice to you see on what looks to be a sunny day here on the Pharmalot corporate campus. The summer haze may have arrived, but we remain as busy as ever. So please join as we quaff o ... more
In a dramatic move, a drugmaker that hoped to become a #8220;fully integrated specialty pharmaceutical company, #8221; complete with its own sales force targeting doctors in the US and R #038;D progr ... more
After what appeared to be a slowdown in layoffs taking place in the pharmaceutical industry, job cuts are accelerating again, according to the latest monthly tally from Challenger, Gray #038; Christm ... more
Rising pressure to find new products is prompting big pharmaceutical companies to license or acquire biotechnology companies' experimental medicines when they've barely been tested in human trials. ... more
Rising pressure to find new products is prompting big pharmaceutical companies to license or acquire biotechnology companies' experimental medicines when they've barely been tested in human trials. ... more
Updated Date: Aug 3, 2010 EST ... more
Updated Date: Aug 3, 2010 EST ... more
Hello, everyone, and welcome to another busy day. This may be the sleepy stretch of summer, but the world is spinning as quickly as ever, yes? And so we must prepare for still more deadlines and meeti ... more
by Marianna Rakovitsky, RPh Oh, Summer! The weather is warm, the sun is shining and it is the time when we try to get outside as much as possible. Summer is my favorite time of the ... more
by Charles Bankhead Reanalysis of a landmark cholesterol-lowering trial of people typically considered at low risk for heart attacks indicated that the results are flawed #8212; and ... more
Welcome back, everyone. We hope your weekend was relaxing and you had time to do something special. Now, though, the routine returns and this means gearing up for those meetings and deadlines. Please ... more
An effort in Massachusetts to repeal a controversial law that prohibits drugmakers from giving gifts and meals to doctors and other healthcare professional has apparently ended. The provision, which h ... more
There was a 13 percent drop in the number of animals used for toxicology testing last year in the UK - to slightly more than 672,000 - although overall usage is up since the beginning of the decade, a ... more
by Merrill Goozner The Center for Medicare and Medicaid Services could save a half billion dollars a year by switching its beneficiaries with macular degeneration to Genetench #8 ... more
Hello, everyone, and top of the morning to you. #8216;Tis a shiny day here on the Pharmalot corporate campus, where we look forward to a relaxing weekend of reading, walking our official Pharmalot ma ... more
Last week, the FDA issued one of those surprise product approvals by giving a thumbs up to a generic version of Lovenox, a widely used bloodthinner sold by Sanofi-Aventis, much sooner than most people ... more
Ascendis has a technology that allows drugs to be released into the body in a controlled way over time, according to its website. The company focuses on hormone-related disorders and is developing ... more
Ascendis has a technology that allows drugs to be released into the body in a controlled way over time, according to its website. The company focuses on hormone-related disorders and is developing ... more
To what extent, if any, should restrictions be placed on prescribing powerful painkillers that are increasingly linked to abuse and overdose deaths? That issue is being debated in the state of Washing ... more
by Crystal Phend Homocysteine-lowering supplements do not help prevent further cardiovascular events in heart attack survivors, a large randomized trial affirmed. The trial, which fol ... more
Updated Date: Jul 29, 2010 EST ... more
Antares Pharma, Inc. (NYSE Amex:AIS) announced positive results from its Phase 3 study of AnturolTM Gel in patients with overactive bladder (OAB). The study met its primary endpoint of a statistically ... more
Most people know generics are less expensive than brand-name meds. But what about the folks who administer Medicaid programs? A new report argues that roughly $271 million could have been saved last y ... more
2010 Prix Galien USA Candidates Announced: Best in Biopharmaceutical and Medical Technology -- NEW YORK, July 28 /PRNewswire/ --: "Final candidates for the Prix Galien USA 2010 Awards are:Abbott (PLEX ... more
2010 Prix Galien USA Candidates Announced: Best in Biopharmaceutical and Medical Technology -- NEW YORK, July 28 /PRNewswire/ --: "Final candidates for the Prix Galien USA 2010 Awards are:Abbott (PLEX ... more
by Claudia M. Gold, MD I recently received a call from a mother that made me both want to cry and scream out in frustration. Several months ago I wrote a post entitled Drugs for Child ... more
Updated Date: Jul 28, 2010 EST ... more
Updated Date: Jul 28, 2010 EST ... more
Updated Date: Jul 28, 2010 EST ... more
In the latest twist in the ongoing battle over whether sales reps should be paid overtime, a federal court in New Jersey last week ruled that an Alpharma rep is exempt from the overtime provisions of ... more
File this under #8217;should have known better. #8217; Last year, GlaxoSmithKline wanted to promote its Avodart drug for shrinking enlarged prostates, so it paid for a supplement in the May 2009 edit ... more
In yet another bid to slash costs, GlaxoSmithKline is turning compensation for sales reps upside down. The drugmaker will no longer pay bonuses based on achieving sales targets and, instead, will pay ... more
... more
Unlike any other book about the pharmaceutical industry, Mike Wokasch a 30 year industry veteran, delves into the causes of the industry €™s current state of dysfunction. He provides practical solut ... more
Jim has the story ... more
Sharing the cost of expensive new cancer medicine with drugs companies is becoming increasingly common but the complexity of the reimbursement procedure means around half the total costs are not bein ... more
... more
Unlike any other book about the pharmaceutical industry, Mike Wokasch a 30 year industry veteran, delves into the causes of the industry €™s current state of dysfunction. He provides practical solut ... more
Jim has the story ... more
Sharing the cost of expensive new cancer medicine with drugs companies is becoming increasingly common but the complexity of the reimbursement procedure means around half the total costs are not bein ... more
by Charles Bankhead Increased emphasis on conflicts of interest has yet to sway physicians #8217; generally positive attitudes toward drug and device manufacturers #8217; marketing ac ... more
by James Baker, MD Clinical psychologist Irving Kirsch is selling a new book in which he argues that anti-depressants aren #8217;t much better than placebo. He bases his claim on ... more
Updated Date: Jul 27, 2010 EST ... more
ST. PAUL, Minn. – While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the ri ... more
Seattle Genetics, Inc. (Nasdaq:SGEN) and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment ... more
Top of the morning to you. A relatively balmy day here on the Pharmalot corporate campus, where we are preparing for some important events. What about you? Are significant meetings on the horizon? And ... more
The general idea behind a patient brochure is to sell a drug, but the FDA, as you know, also wants a drugmaker to include comprehensive, easy-to-find, readable info about safety and effectiveness, too ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more
Updated Date: Jul 20, 2010 EST ... more